Shot
Major dailies misrepresent the Delimitation bill defeat as a setback for women’s reservation
The defeat of the Constitution (131st Amendment) Bill, 2026, in the Lok Sabha on Friday has triggered a wave of misrepresentation. The NDA government-backed legislation aimed to use 2011 Census data to reapportion Lok Sabha seats under the guise of fast-tracking women's reservation. A united Opposition defeated the move, yet their decision has been widely misinterpreted.
Most newspapers, barring a few notable exceptions, have chosen headlines that misrepresent what actually transpired in the Lok Sabha. The truth is simple: the Women’s Reservation Act remains intact. Passed in September 2023, this legislation is officially in force, even if its implementation is linked to the first delimitation exercise after 2027. In a landmark session, the reservation law passed 452-2 in the Lok Sabha and was cleared unanimously in the Rajya Sabha the following day.
To suggest the women's reservation bill “fell” this Friday is to ignore a law that is already on the books.
A quick reading of our four major English-language news dailies reveals a troubling trend of building on a narrative that the ruling BJP has set.
The Indian Express was economical with the truth in their headline, which read, “Opposition stands, women's Bill falls” – suggesting a total collapse of the gender-based legislation that simply did not happen. In their copy, however, they did mention the “amended women's quota bill – the 2023 women's reservation law still stands – was put to a vote…” This crucial context was in the copy while the headline highlighted a false narrative.
Similarly, the Hindustan Times ran with “Delimitation divide defeats bill to raise LS seats for women's quota.” Their strapline went a step further, highlighting a verbal assurance by Home Minister Amit Shah for a 50 percent rise in seats for all states – a pointless promise considering it was not mentioned in the original bill.
The Times of India took the government's narrative peddling to another level. Their headline, “Women's quota, delimitation: Opposition kills bill in Lok Sabha, NDA govt's first legislative defeat,” framed the event as a moral failure of the Opposition.
The introductory paragraph leaned heavily into the drama of a “conscience vote” and a “last-minute appeal”, yet India's largest-selling English daily failed to mention the most crucial detail: the Women's Reservation Bill was passed in 2023. By conflating the two, they have provided a shield for a government attempting to use women’s empowerment as a Trojan horse for seat reapportionment.
The Hindu was the only major outlet to get it right. Its headline read: “Constitution Amendment Bill, part of delimitation package, defeated.” The report maintained a clear factual line, noting that the bill fell short of the two-thirds mark of 352 votes, securing only 298 in favour.
While it acknowledged the BJP's warning that the Opposition would face the "wrath of women" voters, it correctly identified the defeated legislation as a delimitation package rather than the women’s reservation bill itself.
Meanwhile, the BJP has already paid for ads in various publications today, noting that the “Congress revealed its anti-women mindset, rejecting women's reservation.” In other words, the headlines of some of our biggest English-language dailies look indistinguishable from these political ads on their back pages.
Elections are not just about who wins, but about the questions that often go unasked – and this time, they matter more than ever. Support our new NL Sena on the five upcoming assembly polls to help us follow the missing voters, the shifting politics, and the stories that could shape India’s future.
Also Read
-
Opioids without oversight: The Indian pipeline feeding West Africa’s crisis
-
Constitution amendment defeated in Lok Sabha, fails to get two-thirds majority
-
Bengal’s migrant workers caught between ‘ghuspaithiya’ politics and SIR deletions
-
Tuning into Kolkata’s mann ki baat
-
After 66 child deaths, a clean chit, and a ‘vanishing act’: Maiden Pharma is coming back, rebranded